These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF-κB. Takeda T; Tsubaki M; Asano R; Itoh T; Imano M; Satou T; Nishida S J Dermatol Sci; 2020 Sep; 99(3):168-176. PubMed ID: 32693971 [TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma. Froehlich TC; Müller-Decker K; Braun JD; Albrecht T; Schroeder A; Gülow K; Goerdt S; Krammer PH; Nicolay JP Blood; 2019 Aug; 134(5):445-455. PubMed ID: 31167801 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554 [TBL] [Abstract][Full Text] [Related]
6. Dimethyl Fumarate Induces Apoptosis Maeta T; Sato T; Asano K; Ito S Anticancer Res; 2022 May; 42(5):2301-2309. PubMed ID: 35489748 [TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. Kastrati I; Siklos MI; Calderon-Gierszal EL; El-Shennawy L; Georgieva G; Thayer EN; Thatcher GR; Frasor J J Biol Chem; 2016 Feb; 291(7):3639-47. PubMed ID: 26683377 [TBL] [Abstract][Full Text] [Related]
8. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794 [TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma. Biskup E; Kamstrup MR; Manfé V; Gniadecki R Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study. Wu J; Wood GS JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641 [TBL] [Abstract][Full Text] [Related]
11. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Jain S; Stroopinsky D; Yin L; Rosenblatt J; Alam M; Bhargava P; Clark RA; Kupper TS; Palmer K; Coll MD; Rajabi H; Pyzer A; Bar-Natan M; Luptakova K; Arnason J; Joyce R; Kufe D; Avigan D Blood; 2015 Jul; 126(3):354-62. PubMed ID: 26048911 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503 [TBL] [Abstract][Full Text] [Related]
13. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells. Alexander-Savino CV; Hayden MS; Richardson C; Zhao J; Poligone B Oncotarget; 2016 Nov; 7(46):75954-75967. PubMed ID: 27732942 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. Braun FK; Al-Yacoub N; Plötz M; Möbs M; Sterry W; Eberle J J Invest Dermatol; 2012 Feb; 132(2):429-39. PubMed ID: 22011910 [TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373 [TBL] [Abstract][Full Text] [Related]
16. Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance. Shao W; Growney JD; Feng Y; O'Connor G; Pu M; Zhu W; Yao YM; Kwon P; Fawell S; Atadja P Int J Cancer; 2010 Nov; 127(9):2199-208. PubMed ID: 20127862 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma. Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859 [TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma. Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653 [TBL] [Abstract][Full Text] [Related]
19. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. Zhang C; Li B; Zhang X; Hazarika P; Aggarwal BB; Duvic M J Invest Dermatol; 2010 Aug; 130(8):2110-9. PubMed ID: 20393484 [TBL] [Abstract][Full Text] [Related]
20. Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP. Tsubaki M; Ogawa N; Takeda T; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Satou T; Nishida S Biomed Pharmacother; 2014 Oct; 68(8):999-1005. PubMed ID: 25443417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]